Wednesday, January 29, 2020

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action

USFDA cautions Aurobindo Pharma#39;s oral solids formulation facility of regulatory action The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

from Moneycontrol Business News https://ift.tt/2RCYxBJ

No comments:

Post a Comment

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...